25682-022 : Ultomiris 300 mg/30ml Intravenous Solution, Concentrate
| NDC: | 25682-022 |
| Labeler: | Alexion Pharmaceuticals Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Ultomiris |
| Dosage Form: | Intravenous Solution, Concentrate |
| Application #: | BLA761108 |
| Rev. Date: |
NDC Package Codes:
- 25682-022-01: 1 VIAL, GLASS IN 1 CARTON (25682‑022‑01) > 30 ML IN 1 VIAL, GLASS
Active Ingredients:
- Ravulizumab
Dosage Strength:
- 300 mg/30mL
Pharmaceutical Classes:
- Complement Inhibitor [EPC]
- Complement Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 25682-025 Ultomiris 300 mg/3ml Intravenous Solution, Concentrate by Alexion Pharmaceuticals Inc.
- 25682-028 Ultomiris 1100 mg/11ml Intravenous Solution, Concentrate by Alexion Pharmaceuticals Inc.
- 25682-031 UltomirisUltomiris Kit by Alexion Pharmaceuticals Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 25682-019Next: 25682-025 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.